← Back to Search

Procedure

Treatment: Photobiomodulation therapy (PBMt) for Sports Concussion

N/A
Recruiting
Led By Summer Ott, PsyD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (3-7 days post injury), visit 2 (10-14 days post injury), visit 3 (30 days post injury)
Awards & highlights

Study Summary

This trial aims to compare the effects of Photobiomodulation therapy (PBMt) to the standard care for adolescent athletes who are at risk for delayed recovery from sports-related concussions. They

Who is the study for?
This trial is for adolescent athletes who are experiencing a slow recovery from recent sports-related concussions. Participants must be in the subacute phase of concussion, meaning they're past the initial injury but still have symptoms. They should not yet have received any other treatment for their concussion.Check my eligibility
What is being tested?
The study is testing Photobiomodulation therapy (PBMt), which uses light to promote healing, against the standard care given for concussions. The goal is to see if PBMt can speed up recovery. Researchers will also use advanced MRI scans to look at how the brain's connections change over time with this treatment.See study design
What are the potential side effects?
Since PBMt involves using light therapy, potential side effects may include discomfort or irritation at the site of application, headache, fatigue or dizziness post-treatment. However, these tend to be mild and temporary.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (3-7 days post injury), visit 2 (10-14 days post injury), visit 3 (30 days post injury)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (3-7 days post injury), visit 2 (10-14 days post injury), visit 3 (30 days post injury) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS) as assessed by MRI of the brain
Change in Fractional Anisotropy (FA) of compact white matter as assessed by MRI of the brain
Change in Radial Diffusivity (RD) of compact white matter as assessed by MRI of the brain
+5 more
Secondary outcome measures
Change in cognitive function as assessed by composite score on the Impulse Control component of the ImPACT Concussion Test
Change in cognitive function as assessed by composite score on the Reaction Time component of the ImPACT Concussion Test
Change in cognitive function as assessed by composite score on the Verbal Memory component of the ImPACT Concussion Test
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment: Photobiomodulation therapy (PBMt)Experimental Treatment2 Interventions
Group II: ControlActive Control1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
914 Previous Clinical Trials
324,342 Total Patients Enrolled
TIRR Foundation Mission ConnectUNKNOWN
Summer Ott, PsyDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
~20 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top